Patents by Inventor John Blacker

John Blacker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11965219
    Abstract: A process for reducing microbial growth in solutions of sugars extracted from waste materials, the process comprising monitoring indicators of microbial growth in the solution in situ and administering an antimicrobial; a sugar substrate obtained by concentrating a solution of sugar treated using the process; an apparatus for extracting sugars from waste materials, the apparatus comprising a reaction vessel (10), one or more sensors (15,20) for monitoring indicators of microbial growth in the reaction vessel, a software for analysing signals from the sensor and a source of antimicrobial.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: April 23, 2024
    Assignee: UNIVERSITY OF LEEDS
    Inventors: Andrew John Blacker, Richard Anthony Bourne, William Robert Reynolds
  • Publication number: 20210207230
    Abstract: A process for reducing microbial growth in solutions of sugars extracted from waste materials, the process comprising monitoring indicators of microbial growth in the solution in situ and administering an antimicrobial; a sugar substrate obtained by concentrating a solution of sugar treated using the process; an apparatus for extracting sugars from waste materials, the apparatus comprising a reaction vessel (10), one or more sensors (15,20) for monitoring indicators of microbial growth in the reaction vessel, a software for analysing signals from the sensor and a source of antimicrobial.
    Type: Application
    Filed: May 14, 2019
    Publication date: July 8, 2021
    Applicant: UNIVERSITY OF LEEDS
    Inventors: Andrew John Blacker, Richard Anthony Bourne, William Robert Reynolds
  • Publication number: 20210017556
    Abstract: A process for oxidising a substrate selected from hydroxymethylfurfural (HMF), diformylfuran (DFF), hydroxymethylfurancarboxylic acid (HMFCA) and formylfurancarboxylic acid (FFCA). Said process comprises mixing said substrate with catalase, one or more further enzymes and hydrogen peroxide to form a reaction mixture. Said one or more further enzymes have the ability to catalyse oxidation of said substrate. Said hydrogen peroxide is provided at a total molar ratio of at least about 0.1:1 hydrogen peroxide to substrate.
    Type: Application
    Filed: March 26, 2019
    Publication date: January 21, 2021
    Inventors: Paul MINES, Paul LAW, Andrew CARNELL, Shane MCKENNA, John BLACKER, Nikil KAPUR
  • Patent number: 10717754
    Abstract: Metal complexes such as those of formula (I) are contemplated by the present invention. The metal complexes may be used in catalytic reactions as a catalyst. The catalytic reaction may be an autotransfer process, for example hydrogen borrowing. Improved catalytic activity has been observed with certain metal complexes of the invention.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: July 21, 2020
    Assignee: University of Leeds
    Inventors: Stephen Philip Marsden, Patrick Columba McGowan, Roberta Lanaro, Andrew John Blacker
  • Publication number: 20180362566
    Abstract: Metal complexes such as those of formula (I) are contemplated by the present invention. The metal complexes may be used in catalytic reactions as a catalyst. The catalytic reaction may be an autotransfer process, for example hydrogen borrowing.
    Type: Application
    Filed: December 19, 2016
    Publication date: December 20, 2018
    Inventors: Stephen Philip MARSDEN, Patrick Columba MCGOWAN, Roberta LANARO, Andrew John BLACKER
  • Publication number: 20150107965
    Abstract: A screw element for a screw conveyor, said screw element comprising a hub portion having a generally circular bore axially therethrough, and a spiral flight portion extending around said hub in a generally helical path; characterised in that said element comprises engagement means at each axial end thereof for mating with an adjacent element whereby torque may be transmitted between two or more adjacent screw elements via said engagement means.
    Type: Application
    Filed: February 27, 2013
    Publication date: April 23, 2015
    Inventor: Kim John Blacker Price
  • Patent number: 8865924
    Abstract: The present invention relates to compounds and their use as ligands, in particular, in metal catalyst complexes. The ligands of the invention are capable of binding to a solid support. The invention includes the ligands in their own right and when bound to a support and the compounds may be used to prepare metal catalyst complexes.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: October 21, 2014
    Assignee: University of Leeds
    Inventors: John Blacker, Kevin Treacher, Thomas Screen
  • Publication number: 20130267725
    Abstract: The present invention relates to compounds and their use as ligands, in particular, in metal catalyst complexes. The ligands of the invention are capable of binding to a solid support. The invention includes the ligands in their own right and when bound to a support and the compounds may be used to prepare metal catalyst complexes.
    Type: Application
    Filed: June 7, 2013
    Publication date: October 10, 2013
    Applicant: UNIVERSITY OF LEEDS
    Inventors: John Blacker, Kevin Treacher, Thomas Screen
  • Patent number: 8501829
    Abstract: The present invention relates to compounds and their use as ligands, in particular in metal catalyst complexes. The ligands of the invention are capable of binding to a solid support. The invention includes the ligands in their own right and when bound to a support and the compounds may be used to prepare metal catalyst complexes.
    Type: Grant
    Filed: January 9, 2009
    Date of Patent: August 6, 2013
    Assignee: NPIL Pharmaceuticals (UK) Limited
    Inventors: John Blacker, Kevin Treacher, Thomas Screen
  • Patent number: 7888083
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: February 15, 2011
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Publication number: 20100298457
    Abstract: The present invention relates to compounds and their use as ligands, in particular in metal catalyst complexes. The ligands of the invention are capable of binding to a solid support. The invention includes the ligands in their own right and when bound to a support and the compounds may be used to prepare metal catalyst complexes.
    Type: Application
    Filed: January 9, 2009
    Publication date: November 25, 2010
    Applicant: NPIL PHARMACEUTICALS (UK) LIMITED
    Inventors: John Blacker, Kevin Treacher, Thomas Green
  • Publication number: 20100209984
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Application
    Filed: April 27, 2010
    Publication date: August 19, 2010
    Applicant: AstraZeneca UK Limited
    Inventors: Andrew John BLACKER, Christopher David REEVE, Robert Anthony HOLT
  • Patent number: 7732171
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: July 23, 2008
    Date of Patent: June 8, 2010
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Publication number: 20090163719
    Abstract: There is provided a process for the de-enrichment of enantiomerically enriched compositions which comprises reacting an enantiomerically enriched composition comprising at least a first enantiomer or diastereomer of a substrate comprising a carbon-heteroatom bond, wherein the carbon is a chiral centre and the heteroatom is a group V heteroatom, in the presence of a catalyst system and optionally a reaction promoter to give a product composition comprising first and second enantiomers or diastereomers of the substrate having a carbon-heteroatom bond, the ratio of second to first enantiomer or diastereomer in the product composition being greater than the ratio of second to first enantiomer or diastereomer in the enantiomerically enriched composition.
    Type: Application
    Filed: October 27, 2005
    Publication date: June 25, 2009
    Inventors: Andrew John Blacker, Matthew John Stirling
  • Publication number: 20090069579
    Abstract: A process for preparing intermediate compounds useful in the preparation of statins. The process is particularly useful for the preparation of atorvastatin. The process involves the reduction of two ketone groups at the same time using either a chiral transition metal catalyst or an enzyme based system.
    Type: Application
    Filed: November 21, 2006
    Publication date: March 12, 2009
    Inventors: John Blacker, Robin Fieldhouse
  • Publication number: 20080280336
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Application
    Filed: July 23, 2008
    Publication date: November 13, 2008
    Applicant: ASTRAZENECA UK LIMITED
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Anthony Holt
  • Patent number: 7416865
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: August 26, 2008
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Patent number: 7408082
    Abstract: The present invention relates to a novel process for obtaining (1S,4S)N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine from a mixture of its isomers. The process involves isomerising the 1-position and the 4-position and effecting separation of the desired isomer by methods such as fractured crystallization. The process can be operated as a continuous process.
    Type: Grant
    Filed: August 9, 2007
    Date of Patent: August 5, 2008
    Assignee: NPIL Pharmaceuticals (UK) Limited
    Inventor: John Blacker
  • Patent number: 7250526
    Abstract: A catalytic transfer hydrogenation process is provided. The catalyst employed in the process is a metal hydrocarbyl complex which is coordinated to defined bidentate ligands substituted with at least one group selected from an optionally substituted sulphonated hydrocarbyl group, a sulphonated perhalogenated hydrocarbyl group, or an optionally substituted sulphonated heterocyclyl group. Preferred metals include rhodium, ruthenium and iridium. Preferred bidentate ligands are diamines and aminoalcohols, particularly those comprising chiral centres. The hydrogen donor is advantageously a secondary alcohol or a mixture of triethylamine and formic acid. The process can be employed to transfer hydrogenate ketones and imines, which are preferably prochiral. Catalysts for use in such a process are also provided.
    Type: Grant
    Filed: November 29, 2001
    Date of Patent: July 31, 2007
    Assignee: NPIL Pharmaceuticals (UK) Limited
    Inventors: Andrew John Blacker, Christian Bubert, Jonathan Michael Jeremy Williams, Stephen Martin Brown
  • Patent number: 7157255
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: May 1, 2001
    Date of Patent: January 2, 2007
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt